We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Refining tools to bridge the gap between academia and chemical regulation: perspectives for WikiREACH
Summary
This paper proposed improvements to how chemical risk assessors access and use scientific literature data, arguing that better data infrastructure could lead to more comprehensive regulatory hazard assessments. Improved data availability is also relevant to microplastic risk assessment, where literature is rapidly growing and difficult to synthesize.
Regulatory hazard and risk assessments of chemical substances have to include all reliable and relevant data to be credible and complete. However, screening the literature for appropriate studies and extracting data is burdensome. Therefore, reducing impediments by making data easily and readily accessible to risk assessors could result in more comprehensive hazard and risk assessments. In this paper, we study WikiPharma, a database that aggregates ecotoxicity data for pharmaceuticals, extracted from peer-reviewed studies. The use of the WikiPharma database is explored to develop strategies on how similar tools can bridge between science and policy by providing risk assessors with easily accessible summary data. Specifically, adapting the concept of WikiPharma to industrial chemicals regulated under the REACH regulation is discussed. Experiences with WikiPharma show that there is interest in using peer-reviewed studies in regulatory decision-making. However, tools like WikiPharma require constant updates. Hence, as for "WikiREACH", effective incentives are needed to motivate researchers to feed in relevant data for regulatory assessments. Besides, support by automated processes can aid in the labour-intensive activity of gathering data. To ensure that such a tool is continuously maintained and compatible with the regulatory system, and thereby useful for hazard and risk assessments of chemicals, it would benefit from being developed in collaboration with the major stakeholders in the field, i.e. regulatory agencies, academia, industry, scientific journals, and providers of research network platforms.
Sign in to start a discussion.
More Papers Like This
Gaps and Pathways Towards Standardized, FAIR Microplastics Data Harmonization: A Systematic Review
This systematic review examines why microplastic research data is so hard to compare across studies. It finds that a lack of standardized methods for collecting, analyzing, and reporting microplastic data is a major barrier, and proposes a framework for making research more consistent and useful for understanding health risks.
Screening and prioritization of nano- and microplastic particle toxicity studies for evaluating human health risks – development and application of a toxicity study assessment tool
Researchers developed a standardized tool to screen and rank toxicity studies on nano- and microplastics by quality and relevance, addressing a critical gap in how scientists evaluate which studies should inform human health risk assessments for these widespread plastic pollutants.
Plastic pollution: Where are we regarding research and risk assessment in support of management and regulation?
This review assessed the current state of microplastic research and risk assessment, concluding that more exposure-response studies using standardized methods and material-specific metrics are needed to support effective management and regulation of plastic pollution.
Aggregate exposure pathways for microplastics (mpAEP): An evidence-based framework to identify research and regulatory needs
An aggregate exposure pathway framework for microplastics was developed to organize and integrate fragmented data on microplastic sources, environmental levels, and toxicity in a way that supports human and ecological risk assessment, identifying critical research and data gaps.
Paradigms to assess the human health risks of nano- and microplastics
Researchers proposed a new, comprehensive framework for assessing the health risks of nano- and microplastics (tiny plastic particles), addressing key gaps in how we analyze these particles, model their behavior, and use that information to protect human health — since no such standard risk assessment system currently exists.